The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Leflunomide: mode of action in the treatment of rheumatoid arthritis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
Arend, W. P., & Dayer, J. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380202 · Cited by 891
Self-citationSmolen, J. S., Kalden, J. R., Scott, D. L., Rozman, B., Kvien, T. K., Larsen, A., Loew-Friedrich, I., Oed, C., & Rosenburg, R. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09403-3 · Cited by 771
Treatment of Active Rheumatoid Arthritis With Leflunomide Compared With Placebo and Methotrexate
Strand, V. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.21.2542 · Cited by 754
Pyrimidine Nucleotide Biosynthesis in Animals: Genes, Enzymes, and Regulation of UMP Biosynthesis
Jones, M. E. (1980) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.49.070180.001345 · Cited by 721
Linke, S. P., Clarkin, K. C., Di Leonardo, A., Tsou, A., & Wahl, G. M. (1996) · Genes & Development · doi:10.1101/gad.10.8.934 · Cited by 538
Emery, P., Breedveld, F. C., Lemmel, E. M., Kaltwasser, J. P., Dawes, P. T., Gömör, B., Van den Bosch, F., Nordström, D., Bjørneboe, O., Dahl, R., et al. (2000) · Rheumatology · doi:10.1093/rheumatology/39.6.655 · Cited by 472
Self-citationImportance of Ribonucleotide Availability to Proliferating T-lymphocytes from Healthy Humans
Fairbanks, L. D., Bofill, M., Ruckemann, K., & Simmonds, H. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.50.29682 · Cited by 310
Mladenovic, V., Domljan, Z., Rozman, B., Jajic, I., Mihajlovic, D., Dordevic, J., Popovic, M., Dimitrijevic, M., Zivkovic, M., Campion, G., et al. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780381111 · Cited by 303
Davis, J. P., Cain, G. A., Pitts, W. J., Magolda, R. L., & Copeland, R. A. (1996) · Biochemistry · doi:10.1021/bi952168g · Cited by 293
Herrmann, M. L., Schleyerbach, R., & Kirschbaum, B. J. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)00191-0 · Cited by 273
Rückemann, K., Fairbanks, L. D., Carrey, E. A., Hawrylowicz, C. M., Richards, D. F., Kirschbaum, B., & Simmonds, H. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.34.21682 · Cited by 270
Cherwinski, H. M., Cohn, R. G., Cheung, P., Webster, D. J., Xu, Y. Z., Caulfield, J. P., Young, J. M., Nakano, G., & Ransom, J. T. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12093-4 · Cited by 222
Xu, X., Williams, J. W., Bremer, E. G., Finnegan, A., & Chong, A. S.-F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.21.12398 · Cited by 216
Manna, S. K., & Aggarwal, B. B. (1999) · PubMed · Cited by 208
Inhibition of dihydroorotate dehydrogenase by the immunosuppressive agent leflunomide
Greene, S., Watanabe, K., Braatz-Trulson, J., & Lou, L. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00255-x · Cited by 197
Brazelton, T. R., & Randall E, M. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80090-2 · Cited by 195
Guidelines for monitoring drug therapy in rheumatoid arthritis
American College of Rheumatology AD Hoc Committee on Clinical Guidelines (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390503 · Cited by 193
Williamson, R. A., Yea, C. M., Robson, P. A., Curnock, A. P., Gadher, S., Hambleton, A. B., Woodward, K., Bruneau, J.-M., Hambleton, P., Moss, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.38.22467 · Cited by 192
Manna, S. K., & Aggarwal, B. B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2095 · Cited by 187
REGULATION OF B CELL FUNCTION BY THE IMMUNOSUPPRESSIVE AGENT LEFLUNOMIDE1
Siemasko, K. F., Chong, A. S. F., Williams, J. W., Bremer, E. G., & Finnegan, A. (1996) · Transplantation · doi:10.1097/00007890-199602270-00020 · Cited by 183
Simms, R. W., Kwoh, C. K., Anderson, L. G., Erlandson, D. M., Greene, J. M., Kelleher, M. E., O’Dell, J. R., Partridge, A. J., Roberts, W. N., Robbins, M. L., et al. (1996) · PubMed · Cited by 182
Lacraz, S., Isler, P., Vey, E., Welgus, H. G., & Dayer, J. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31750-7 · Cited by 177
Self-citationElder, R. T., Xu, X., Williams, J. W., Gong, H., Finnegan, A., & Chong, A. S. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.1.22 · Cited by 174
Siemasko, K., Chong, A. S.-F., Jäck, H.-M., Gong, H., Williams, J. W., & Finnegan, A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.4.1581 · Cited by 174
Vey, E., Zhang, J. H., & Dayer, J. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.6.2040 · Cited by 154
Self-citationp53 mediates permanent arrest over multiple cell cycles in response to gamma-irradiation.
Linke, S. P., Clarkin, K., & Wahl, G. M. (1997) · PubMed · Cited by 143
Two activities of the immunosuppressive metabolite of leflunomide, A77 1726
Xu, X., Williams, J. W., Gong, H., Finnegan, A., & Chong, A. S. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00303-6 · Cited by 138
Bartlett, R. R., & Schleyerbach, R. (1985) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(85)90003-7 · Cited by 131
Isler, P., Vey, E., Zhang, J., & Dayer, J. (1993) · PubMed · Cited by 118
Self-citationMaintaining genetic stability through TP53 mediated checkpoint control.
Wahl, G. M., Sp, L., Tg, P., & Huang, L. (1997) · PubMed · Cited by 115
Cherwinski, H. M., McCarley, D. L., Schatzman, R. C., et al. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24292-6 · Cited by 101
Leflunomide interferes with pyrimidine nucleotide biosynthesis
Cherwinski, H. M., Byars, N. E., Ballaron, S. J., Nakano, G., Young, J. M., & Ransom, J. T. (1995) · Inflammation Research · doi:10.1007/bf01796261 · Cited by 99
IN VIVO ACTIVITY OF LEFLUNOMIDE
Chong, A. S., Huang, W., Liu, W., Luo, J., Shen, J., Xu, W. M., Ma, L., Blinder, L., Xiao, F., Xu, X., et al. (1999) · Transplantation · doi:10.1097/00007890-199907150-00020 · Cited by 98
Kremer, J. M. (1999) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(99)80034-1 · Cited by 93
Leflunomide and Malononitrilamides
Junior, H. T. S., & Morris, R. E. (1997) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199705000-00008 · Cited by 92
LEFLUNOMIDE, A NOVEL IMMUNOSUPPRESSIVE AGENT
Chong, A. S., Finnegan, A., JIANG, X., et al. (1993) · Transplantation · doi:10.1097/00007890-199306000-00028 · Cited by 91
Kuo, E., Hambleton, P. T., Kay, D. P., Evans, P. L., Matharu, S. S., Little, E., McDowall, N., Jones, C. B., Hedgecock, C. J. R., Yea, C., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9604437 · Cited by 91
Chizzolini, C., Chicheportiche, R., Burger, D., & Dayer, J. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270125 · Cited by 89
Self-citationEffects of leflunomide on immune responses and models of inflammation
Bartlett, R. R., Anagnostopulos, H., Zielinski, T. K., et al. (1993) · Springer Seminars in Immunopathology · doi:10.1007/bf00192310 · Cited by 88
Xu, X., Blinder, L., Shen, J., Gong, H., Finnegan, A., Williams, J. W., & Chong, A. S. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.1.167 · Cited by 87
Inhibition of dihydroorotate dehydrogenase activity by brequinar sodium.
Chen, S.-F., Perrella, F. W., Behrens, D. L., & Papp, L. M. (1992) · PubMed · Cited by 83
EFFECTS OF LEFLUNOMIDE AND OTHER IMMUNOSUPPRESSIVE AGENTS ON T CELL PROLIFERATION IN VITRO1
Chong, A. S., Rezai, K., Gebel, H. M., Finnegan, A., Foster, P. F., Xu, X., & Williams, J. W. (1996) · Transplantation · doi:10.1097/00007890-199601150-00026 · Cited by 73
Cao, W. W., Kao, P. N., Chao, A. C., Gardner, P. I., Ng, J., & Morris, R. E. (1995) · PubMed · Cited by 62
Bartlett, R. R. (1986) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(86)90059-7 · Cited by 60
Disease modifying activity of HWA 486 on the development of SLE in MRL/1-mice
Popović, S., & Bartlett, R. R. (1986) · Inflammation Research · doi:10.1007/bf01971235 · Cited by 54
Leflunomide and malononitriloamides
Junior, H. T. S., & Morris, R. E. (1997) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.6.1.51 · Cited by 51
Cao, W., Kao, P. N., Aoki, Y., Xu, J. C., Shorthouse, R., & Morris, R. E. (1996) · PubMed · Cited by 51
Déage, V., Burger, D., & Dayer, J.-M. (1998) · PubMed · Cited by 50
Self-citationLang, R., Wagner, H., & Heeg, K. M. (1995) · Transplantation · doi:10.1097/00007890-199502000-00013 · Cited by 47
Leflunomide prevents the development of experimentally induced myasthenia gravis
Vidic-Dankovic, B., Kosec, D. J., Damjanović, M., et al. (1995) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(95)00009-q · Cited by 41
Dihydroorotate dehydrogenase is a target for the biological effects of leflunomide.
Williamson, R. A., Yea, C., Robson, P. A., et al. (1996) · PubMed · Cited by 41
How Does Leflunomide Modulate the Immune Response in Rheumatoid Arthritis?
Fox, R. I., Herrmann, M. L., Frangou, C. G., Wahl, G. M., Morris, R. E., & Kirschbaum, B. J. (1999) · BioDrugs · doi:10.2165/00063030-199912040-00007 · Cited by 33
In vitro and in vivo effects of leflunomide, Brequinar, and cyclosporine on pyrimidine biosynthesis
Junior, H. T. S., Shorthouse, R., Löffler, M., et al. (1997) · Transplantation Proceedings · doi:10.1016/s0041-1345(96)00523-4 · Cited by 33
Schorlemmer, H. U., Seiler, F. R., & Bartlett, R. R. (1993) · PubMed · Cited by 33
Junior, H. T. S., Cao, W., Shorthouse, R., & Morris, R. E. (1996) · PubMed · Cited by 28
Inhibition of Interleukin 2 (IL-2)-stimulated tyrosine kinase activity by leflunomide
Nikcevich, D. A., Finnegan, A., Chong, A. S., Williams, J. W., & Bremer, E. G. (1994) · Inflammation Research · doi:10.1007/bf01987669 · Cited by 26
Hambleton, P. T., & McMahon, S. (1990) · Inflammation Research · doi:10.1007/bf01966465 · Cited by 26
Novel immunosuppressive butenamides
Axton, C. A., Billingham, M. E. J., Bishop, P. M., Gallagher, P. T., Hicks, T. A., Kitchen, E., Mullier, G. W., Owton, W. M., Parry, M. G., Scott, S. J., et al. (1992) · Journal of the Chemical Society Perkin Transactions 1 · doi:10.1039/p19920002203 · Cited by 18
Thoß, K., Henzgen, S., Petrow, P. K., Katenkamp, D., & Bräuer, R. (1996) · Inflammation Research · doi:10.1007/bf02265123 · Cited by 14
Interactions between T cell plasma membranes and monocytes
Burger, D., & Dayer, J. (1998) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8823-3_6 · Cited by 13
Self-citation
Cited by
Exome sequencing identifies the cause of a mendelian disorder
Ng, S. B., Buckingham, K. J., Lee, C., Bigham, A. W., Tabor, H. K., Dent, K. M., Huff, C. D., Shannon, P. T., Jabs, E. W., Nickerson, D. A., et al. (2010) · Nature Genetics · doi:10.1038/ng.499 · Cited by 1,957
An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis
Chen, J., Wright, K., Davis, J. M., Jeraldo, P., Marietta, E. V., Murray, J., Nelson, H., Matteson, E. L., & Taneja, V. (2016) · Genome Medicine · doi:10.1186/s13073-016-0299-7 · Cited by 858
New Drugs for Rheumatoid Arthritis
Olsen, N. J., & Stein, C. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032906 · Cited by 626
Kaltwasser, J. P., Nash, P., Gladman, D., Rosen, C. F., Behrens, F., Jones, P., Wollenhaupt, J., Falk, F. G., & Mease, P. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20253 · Cited by 413
The role of cathepsins in osteoporosis and arthritis: Rationale for the design of new therapeutics
YASUDA, Y., KALETA, J., & BROMME, D. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.12.013 · Cited by 300
Metadata
- Authors
- Breedveld, F. C., & Dayer, J.-M.
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2000-11
- Volume
- 59
- Issue
- 11
- Pages
- 841-849
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W2154147815
- Cited by
- 485
- References
- 61
- FWCI
- 10.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.